Ionis Pharmaceuticals (IONS) Operating Income (QoQ) (2009 - 2026)
Ionis Pharmaceuticals (IONS) Operating Income (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ionis Pharmaceuticals | 9.21 Bn | 7.29 Bn | 243.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.25% |
| Dec 31, 2025 | -33.88% |
| Sep 30, 2025 | -214.57% |
| Jun 30, 2025 | 195.20% |
| Mar 31, 2025 | -32.52% |
| Dec 31, 2024 | 25.45% |
| Sep 30, 2024 | -124.93% |
| Jun 30, 2024 | 55.80% |
| Mar 31, 2024 | -2,342.22% |
| Dec 31, 2023 | 95.73% |
| Sep 30, 2023 | -58.84% |
| Jun 30, 2023 | 20.98% |
| Mar 31, 2023 | 45.13% |
| Dec 31, 2022 | -251.66% |
| Sep 30, 2022 | 30.83% |
| Jun 30, 2022 | -48.71% |
| Mar 31, 2022 | -126.07% |
| Dec 31, 2021 | 356.97% |
| Sep 30, 2021 | -17.65% |
| Jun 30, 2021 | 20.66% |